Your browser doesn't support javascript.
loading
Comprehensive immune cell profiling depicts an early immune response associated with severe coronavirus disease 2019 in cancer patients.
Tembhare, Prashant R; Sriram, Harshini; Chatterjee, Gaurav; Khanka, Twinkle; Gokarn, Anant; Mirgh, Sumeet; Rajendra, Akhil; Chaturvedi, Anumeha; Ghogale, Sitaram G; Deshpande, Nilesh; Girase, Karishma; Dalvi, Kajal; Rajpal, Sweta; Patkar, Nikhil; Trivedi, Bhakti; Joshi, Amit; Murthy, Vedang; Shetty, Nitin; Nair, Sudhir; More, Ashwini; Kamtalwar, Sujeet; Chavan, Preeti; Bhat, Vivek; Bhat, Prashant; Subramanian, Papagudi G; Gupta, Sudeep; Khattry, Navin.
Afiliación
  • Tembhare PR; Hematopathology Laboratory, ACTREC, Tata Memorial Center, Homi Bhabha National Institute (HBNI) University, Mumbai, India.
  • Sriram H; Hematopathology Laboratory, ACTREC, Tata Memorial Center, Homi Bhabha National Institute (HBNI) University, Mumbai, India.
  • Chatterjee G; Hematopathology Laboratory, ACTREC, Tata Memorial Center, Homi Bhabha National Institute (HBNI) University, Mumbai, India.
  • Khanka T; Hematopathology Laboratory, ACTREC, Tata Memorial Center, Homi Bhabha National Institute (HBNI) University, Mumbai, India.
  • Gokarn A; Department of Medical Oncology, ACTREC, Tata Memorial Center, HBNI University, Mumbai, India.
  • Mirgh S; Department of Medical Oncology, ACTREC, Tata Memorial Center, HBNI University, Mumbai, India.
  • Rajendra A; Department of Medical Oncology, ACTREC, Tata Memorial Center, HBNI University, Mumbai, India.
  • Chaturvedi A; Hematopathology Laboratory, ACTREC, Tata Memorial Center, Homi Bhabha National Institute (HBNI) University, Mumbai, India.
  • Ghogale SG; Hematopathology Laboratory, ACTREC, Tata Memorial Center, Homi Bhabha National Institute (HBNI) University, Mumbai, India.
  • Deshpande N; Hematopathology Laboratory, ACTREC, Tata Memorial Center, Homi Bhabha National Institute (HBNI) University, Mumbai, India.
  • Girase K; Hematopathology Laboratory, ACTREC, Tata Memorial Center, Homi Bhabha National Institute (HBNI) University, Mumbai, India.
  • Dalvi K; Hematopathology Laboratory, ACTREC, Tata Memorial Center, Homi Bhabha National Institute (HBNI) University, Mumbai, India.
  • Rajpal S; Hematopathology Laboratory, ACTREC, Tata Memorial Center, Homi Bhabha National Institute (HBNI) University, Mumbai, India.
  • Patkar N; Hematopathology Laboratory, ACTREC, Tata Memorial Center, Homi Bhabha National Institute (HBNI) University, Mumbai, India.
  • Trivedi B; Department of Anesthesiology, Critical Care and Pain, Tata Memorial Center, HBNI University, Mumbai, India.
  • Joshi A; Department of Medical Oncology, ACTREC, Tata Memorial Center, HBNI University, Mumbai, India.
  • Murthy V; Department of Radiation Oncology, ACTREC, Tata Memorial Center, HBNI University, Mumbai, India.
  • Shetty N; Department of Radio-Diagnosis, ACTREC, Tata Memorial Center, HBNI University, Mumbai, India.
  • Nair S; Department of Head and Neck Surgical Oncology, ACTREC, Tata Memorial Center, HBNI University, Mumbai, India.
  • More A; Department of Medicine, ACTREC, Tata Memorial Center, HBNI University, Mumbai, India.
  • Kamtalwar S; Department of Medicine, ACTREC, Tata Memorial Center, HBNI University, Mumbai, India.
  • Chavan P; Composite Laboratory and Microbiology, ACTREC, Tata Memorial Center, HBNI University, Mumbai, India.
  • Bhat V; Composite Laboratory and Microbiology, ACTREC, Tata Memorial Center, HBNI University, Mumbai, India.
  • Bhat P; Medical Administration, ACTREC, Tata Memorial Center, HBNI University, Mumbai, India.
  • Subramanian PG; Hematopathology Laboratory, ACTREC, Tata Memorial Center, Homi Bhabha National Institute (HBNI) University, Mumbai, India.
  • Gupta S; Department of Medical Oncology, ACTREC, Tata Memorial Center, HBNI University, Mumbai, India.
  • Khattry N; Department of Medical Oncology, ACTREC, Tata Memorial Center, HBNI University, Mumbai, India.
Immunol Cell Biol ; 100(1): 61-73, 2022 01.
Article en En | MEDLINE | ID: mdl-34582592

Texto completo: 1 Colección: 01-internacional Asunto principal: COVID-19 / Neoplasias Tipo de estudio: Risk_factors_studies Límite: Humans Idioma: En Revista: Immunol Cell Biol Asunto de la revista: ALERGIA E IMUNOLOGIA Año: 2022 Tipo del documento: Article País de afiliación: India

Texto completo: 1 Colección: 01-internacional Asunto principal: COVID-19 / Neoplasias Tipo de estudio: Risk_factors_studies Límite: Humans Idioma: En Revista: Immunol Cell Biol Asunto de la revista: ALERGIA E IMUNOLOGIA Año: 2022 Tipo del documento: Article País de afiliación: India